GH promotes DNA damage repair by reducing apoptosis and increasing drug resistance in human endometrial cancer cell AN3CA and breast cancer cell MCF-7 (Zatelli et al., 2009; Gentilin et al., 2017). Here, GH1 is linked to endometrial cancer.